MktsMarkets

Elevance Health, Inc.
NYSE: ELVKey statistics
ELV News
Stories mentioning ELV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 50,181,000 | 49,747,000 | 50,711,000 | 49,776,000 | 48,891,000 | 45,442,000 | 45,106,000 | 43,886,000 |
| Cost of Goods Sold | 5,463,000 | 5,522,000 | 5,380,000 | 5,293,000 | 4,983,000 | 6,012,000 | 5,093,000 | 4,820,000 |
| Gross Profit | 44,718,000 | 44,225,000 | 45,331,000 | 44,483,000 | 43,908,000 | 39,430,000 | 40,013,000 | 39,066,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 6,330,000 | 5,415,000 | 5,272,000 | 4,997,000 | 5,300,000 | 4,804,000 | 5,269,000 | 5,066,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 2,086,000 | 309,000 | 1,295,000 | 2,425,000 | 3,170,000 | 673,000 | 1,408,000 | 2,765,000 |
| Interest Income | ||||||||
| Interest Expense | 300,000 | 280,000 | ||||||
| Other Expense | ||||||||
| Pretax Income | 2,304,000 | 215,000 | 1,406,000 | 2,292,000 | 2,797,000 | 606,000 | 1,373,000 | 2,986,000 |
| Tax Provision | 544,000 | (331,000) | 219,000 | 548,000 | 613,000 | 193,000 | 365,000 | 685,000 |
| Net Income (Loss) | 1,764,000 | 547,000 | 1,189,000 | 1,743,000 | 2,183,000 | 418,000 | 1,016,000 | 2,300,000 |
| Earnings Per Share (Basic) | 8.03 | 2.44 | 5.32 | 7.74 | 9.64 | 1.80 | 4.38 | 9.91 |
| Earnings Per Share (Diluted) | 8.00 | 2.44 | 5.32 | 7.72 | 9.61 | 1.79 | 4.36 | 9.85 |
| Weighted Average Shares Outstanding (Basic) | 219,800 | 224,000 | 223,300 | 225,200 | 226,400 | 231,700 | 231,900 | 232,200 |
| Weighted Average Shares Outstanding (Diluted) | 220,400 | 224,600 | 223,700 | 225,800 | 227,200 | 232,900 | 233,100 | 233,400 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ELV
Elevance Health, Inc. (NYSE: ELV) is a stock listed on the New York Stock Exchange under the ticker symbol ELV. It last traded at $429.48 (Nov 11, 2026, 4:00 PM ET), down 0.0% on the day. That gives Elevance Health a market capitalisation of $92.8B and a price-to-earnings ratio of 18.1.
Over the past 52 weeks ELV has traded between $274.84 and $450.69.
Revenue for the quarter ended Mar 31, 2026 was $50.2B; net income $1.8B. Revenue was up 2.6% from $48.9B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $50.2B | $1.8B | 3.5% |
| Dec 31, 2025 | $49.7B | $547.0M | 1.1% |
| Sep 30, 2025 | $50.7B | $1.2B | 2.3% |
| Jun 30, 2025 | $49.8B | $1.7B | 3.5% |
From Elevance Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…